FDA to Survey Healthcare Providers

The CDER Office of Prescription Drug Promotion (OPDP) plans to survey some 2,400 healthcare providers on topics relating to prescription drug promotion. A Federal Register notice says topics to be surveyed include provider use of the Bad Ad program, understanding of quantitative data displays that may appear in prescription drug promotion, perceptions of trust in FDA, perceptions of medical misinformation, and attitudes about prescription drug promotion on social media.

“These topics were selected to extend previous FDA work on healthcare provider understanding of quantitative data displays, provide an updated snapshot of social media attitudes and Bad Ad program awareness, and help inform FDA’s role in addressing medical misinformation,” the notice says.

OPDP says its target survey respondents are primary care physicians, nurse practitioners, physician assistants, or specialists engaging in patient care at least half-time.